NL-OMON27187尚未招募不适用
Modelling fluctuations in blood glucose levels based on food intake and physical activity in patients with Diabetes Mellitus Type 2
Dr. G.D. Laverman, Internal medicine/nephrology, ZGT Hospital0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Is diagnosed with diabetes mellitus type 2
- •Is aged between 25 and 70 years
- •Receives diabetic treatment based on long term medication
- •Has a BMI between 25 and 40 kg/m2
- •Is able to do 30 min of walking at a steady pace
排除标准
- •Is receiver of short term/acute diabetic medication.
- •Has any gastrointestinal disorder that is expected to have clinical relevant effect on the uptake of nutrients from the gut.
- •Has any medical condition that prevents performing the required procedures.
- •Has uncontrolled thyroid diseases.
- •Is allergic to any substance present in any of the standardized meals.
研究者
相似试验
已完成
不适用
Modelling fluctuations in blood glucose levels based on food intake and physical activity in patients with Diabetes Mellitus Type 2DiabetesType 2 Diabetes MellitusNL-OMON48091Ziekenhuisgroep Twente5
招募中
2 期
A real-world study of blood glucose fluctuation in newly diagnosed overweight type 2 diabetes mellitus by Qingre Lishi decoctiotype 2 diabetesITMCTR2024000006the First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
招募中
不适用
A study of blood glucose fluctuation examined by continous glucose monitoring systemDiabetes MellitusJPRN-UMIN000002569Kobe University Graduate School of Medicine, Division of Diabetes, Metabolism and Endocrinology100
已完成
不适用
The relationship between blood glucose fluctuations and vascular endothelial dysfunction from CGM in type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000007581First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan50
已完成
4 期
Study for the effect on blood glucose fluctuation by switching from DPP-4 inhibitor to SGLT2 inhibitor or to DPP-4 inhibitor/SGLT2 inhibitor combination tablet in patients with type 2 diabetes. - multicenter, prospective, randomized, open-label, parallel group, comparison studytype 2 diabetes mellitusJPRN-UMIN000029628Hokkaido University Hospital101